Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Interaction of ASP1707 and Itraconazole
NCT02175407Phase 1Completed
- Sponsor
- Astellas Pharma
- Start
- Apr 2014
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of opigolix in endometriosis and rheumatoid arthritis (RA) (2 arms), sponsored by Astellas Pharma. Primary endpoints: Area Under the Concentration-Time Curve from Time Zero to Infinity and Maximum Plasma Concentration. Started Apr 2014; status: completed.
02
Drugs
opigolix
03
Conditions
endometriosisrheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02175407.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02175407.